Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Gravidklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   4.9% 4.2% 2.8% 5.1% 1.9% 2.3% 21.1% 21.1%   Credit score (0-100)   46 50 59 42 69 64 5 5   Credit rating   BBB BBB BBB BBB A BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   271 515 735 373 707 887 0.0 0.0   EBITDA   121 269 435 260 425 530 0.0 0.0   EBIT   121 269 435 260 352 413 0.0 0.0   Pre-tax profit (PTP)   120.0 241.5 428.5 256.3 338.9 389.6 0.0 0.0   Net earnings   92.3 188.2 335.1 197.7 257.4 301.8 0.0 0.0   Pre-tax profit without non-rec. items   120 241 429 256 339 390 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 688 572 0.0 0.0   Shareholders equity total   145 244 399 86.3 262 154 4.3 4.3   Interest-bearing liabilities   6.5 32.3 3.2 0.5 321 308 0.0 0.0   Balance sheet total (assets)   262 359 556 226 735 632 4.3 4.3   Net Debt   -236 -315 -535 -205 320 308 -4.3 -4.3     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   271 515 735 373 707 887 0.0 0.0   Gross profit growth   17.8% 90.4% 42.7% -49.2% 89.4% 25.3% -100.0% 0.0%   Employees   2 2 2 2 5 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 150.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   262 359 556 226 735 632 4 4   Balance sheet change%   46.8% 36.8% 55.2% -59.5% 225.9% -14.1% -99.3% 0.0%   Added value   120.7 269.4 434.6 259.6 352.3 529.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 616 -233 -572 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   44.6% 52.3% 59.1% 69.5% 49.8% 46.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   54.8% 86.8% 95.0% 66.4% 73.4% 60.4% 0.0% 0.0%   ROI %   91.1% 126.0% 128.3% 106.3% 103.8% 76.9% 0.0% 0.0%   ROE %   71.4% 96.8% 104.4% 81.5% 147.6% 144.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   55.4% 67.9% 71.6% 38.3% 35.7% 24.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -195.9% -116.9% -123.1% -78.9% 75.4% 58.2% 0.0% 0.0%   Gearing %   4.5% 13.3% 0.8% 0.6% 122.2% 199.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   21.0% 143.8% 34.4% 180.6% 8.3% 7.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   2.1 3.0 3.4 1.5 0.0 0.0 0.0 0.0   Current Ratio   2.1 3.1 3.5 1.6 0.1 0.1 0.0 0.0   Cash and cash equivalent   242.9 347.2 538.4 205.3 0.6 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   129.8 236.0 391.1 78.8 -431.6 -406.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   60 135 217 130 70 106 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   60 135 217 130 85 106 0 0   EBIT / employee   60 135 217 130 70 83 0 0   Net earnings / employee   46 94 168 99 51 60 0 0